Ligand ID: HNQ


Drugbank ID:
DB01422
(Nitroxoline)


Indication:
Nitroxoline is an antibiotic agent.

Get human targets for HNQ in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'HNQ' AND SARS-RELATED PROTEINS ONLY

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		1wnc E2 GLYCOPROTEIN
(SARSr-CoV)		4 / 8
VAL E 934
LEU D 930
LEU F 930
ASN D 935
1.28A24.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		2amq 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 7
GLY A 149
HIS A 163
HIS A 164
CYH A 145
1.57A22.12
None
PJE  C   5 (-3.6A)
None
PJE  C   5 (-1.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_B_HNQB255_1
(CATHEPSIN B)		2amq 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 6
GLY A 149
HIS A 163
HIS A 164
CYH A 145
1.51A22.12
None
PJE  C   5 (-3.6A)
None
PJE  C   5 (-1.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2dd8 IGG HEAVY CHAIN
(Homo
sapiens)		4 / 8
PRO H 185
VAL H 182
LEU H 138
ASN H 155
1.23A16.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		2g9t ORF1A POLYPROTEIN
(SARSr-CoV)		4 / 7
GLN R  65
GLY R  52
HIS R  48
CYH R  46
1.50A21.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		2gdt NSP1 (EC 3.4.22.-)
P65 HOMOLOG
LEADER PROTEIN
(SARSr)		4 / 7
GLY A   1
HIS A  70
HIS A  70
HIS A  72
1.49A21.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_B_HNQB255_1
(CATHEPSIN B)		2gz7 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		4 / 6
GLY A 149
HIS A 163
HIS A 164
CYH A 145
1.42A21.82
None
None
D3F  A 307 (-4.4A)
D3F  A 307 (-4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		2gz7 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		4 / 7
GLY A 149
HIS A 163
HIS A 164
CYH A 145
1.46A21.82
None
None
D3F  A 307 (-4.4A)
D3F  A 307 (-4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		4 / 8
LEU A 200
CYH A 292
TYR A 278
ILE A 280
1.25A14.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2jw8 NUCLEOCAPSID PROTEIN
(SARSr-CoV)		4 / 8
LEU B 332
LEU A 340
ASN A 355
ILE A 358
1.12A20.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2liz 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 8
PRO A 293
VAL A 297
LEU A 253
ILE A 249
0.97A18.44
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		4 / 8
LEU D 200
CYH D 292
TYR D 278
ILE D 280
0.99A15.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)		4 / 8
PRO A 293
VAL A 297
LEU A 253
ILE A 249
1.15A18.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2qcy 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 8
PRO A 293
VAL A 297
LEU A 253
ILE A 249
1.27A18.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		4 / 8
LEU A 200
CYH A 292
TYR A 278
ILE A 280
0.94A16.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		2xyv PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		4 / 8
LEU A 180
LEU A 183
TYR A 211
ILE A 127
1.28A17.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		3ebn REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		4 / 8
PRO D 293
VAL D 297
LEU D 253
ILE D 249
1.21A18.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		3f9e 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 8
PRO A 293
VAL A 297
LEU A 253
ILE A 249
1.23A18.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		3iwm 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 8
PRO A 293
VAL A 297
LEU A 253
ILE A 249
1.13A18.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		3m3t 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 8
PRO A 293
VAL A 297
LEU A 253
ILE A 249
1.23A18.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		4m0w UBIQUITIN
(Bos
taurus)		4 / 8
VAL B  26
LEU B  43
LEU B  50
ILE B   3
1.22A18.40
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		4rna PAPAIN-LIKE PROTEASE
(Human
betacoronavirus
2c
EMC/2012)		4 / 8
PRO A  45
LEU A  54
ASN A  50
ILE A   4
1.24A16.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		4rna PAPAIN-LIKE PROTEASE
(Human
betacoronavirus
2c
EMC/2012)		4 / 7
GLN A 270
GLY A 271
CYH A 305
HIS A 278
1.79A22.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		4tww 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 8
PRO B 293
VAL B 297
LEU B 253
ILE B 249
1.24A18.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 8
PRO A 293
VAL A 297
LEU A 253
ILE A 249
1.22A18.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_B_HNQB255_1
(CATHEPSIN B)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		4 / 6
GLY D 416
HIS D 257
HIS D 260
CYH D 279
1.47A17.24
None
ZN  D 602 (-3.0A)
None
ZN  D 602 (-2.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		4 / 7
GLY D 416
HIS D 257
HIS D 260
CYH D 279
1.42A17.24
None
ZN  D 602 (-3.0A)
None
ZN  D 602 (-2.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		5c8t GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		4 / 7
GLY D 416
HIS D 257
HIS D 260
CYH D 279
1.50A17.24
None
ZN  D 602 (-2.7A)
None
ZN  D 602 (-2.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_B_HNQB255_1
(CATHEPSIN B)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		4 / 6
GLY D 416
HIS D 257
HIS D 283
CYH D 279
1.54A17.24
None
ZN  D 602 (-3.0A)
None
ZN  D 602 (-2.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		5e6j UBIQUITIN
(synthetic
construct)		5 / 8
VAL B  26
LEU B  43
LEU B  50
TYR B  59
ILE B  61
1.73A18.40
None
None
5MW  B  48 ( 4.3A)
5MW  B  48 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		5e6j POLYUBIQUITIN-B
(synthetic
construct)		4 / 8
LEU C  43
LEU C  50
TYR C  59
ILE C  61
1.17A18.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_B_HNQB255_1
(CATHEPSIN B)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		4 / 6
GLY C 416
HIS C 257
HIS C 260
CYH C 279
1.64A17.24
None
ZN  C 602 (-3.5A)
None
ZN  C 602 (-2.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_A_HNQA255_1
(CATHEPSIN B)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		4 / 7
GLY C 416
HIS C 257
HIS C 260
CYH C 279
1.61A17.24
None
ZN  C 602 (-3.5A)
None
ZN  C 602 (-2.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		5tl6 UBIQUITIN-LIKE
PROTEIN ISG15
(Homo
sapiens)		5 / 8
VAL C 104
LEU C 124
LEU C 131
TYR C 140
ILE C  84
1.65A22.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		4 / 8
PRO B 565
VAL B 562
LEU B 571
LEU B 538
1.24A7.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		5x5f S PROTEIN
(MERS-CoV)		4 / 8
VAL C 363
LEU C 347
LEU C 344
ILE C 662
1.21A5.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 8
VAL B1043
LEU B 804
LEU B 927
ILE B 916
1.12A6.57
VAL  B1043 ( 0.6A)
LEU  B 804 ( 0.5A)
LEU  B 927 ( 0.6A)
ILE  B 916 ( 0.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 8
VAL A1043
LEU A 804
LEU A 927
ILE A 916
1.10A6.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 8
VAL C1043
LEU C 804
LEU C 927
ILE C 916
1.19A7.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6crx SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 8
VAL C1043
LEU C 804
LEU C 927
ILE C 916
1.13A7.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6cs2 ACE2
(Homo
sapiens)		4 / 8
PRO D 415
LEU D 439
ASN D 290
ILE D 291
1.22A12.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		4 / 8
PRO C 526
CYH C 299
ASN C 298
ILE C 522
1.24A11.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AI8_B_HNQB255_1
(CATHEPSIN B)		6m1d SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		4 / 6
GLN A 274
GLY A  53
HIS A  65
CYH A  62
1.67A16.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 8
LEU H 138
TYR H 194
ASN H 155
ILE H 195
1.51A16.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 8
PRO H 185
VAL H 182
LEU H 138
ASN H 155
1.46A16.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 8
PRO H 189
VAL H 186
LEU H 142
ASN H 159
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 8
LEU B 142
TYR B 198
ASN B 159
ILE B 199
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 8
PRO B 189
VAL B 186
LEU B 142
ASN B 159
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6ym0 HEAVY CHAIN
(Homo
sapiens)		4 / 8
PRO H 189
VAL H 186
LEU H 142
ASN H 159
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6yor IGG H CHAIN
(Homo
sapiens)		4 / 8
PRO B 189
VAL B 186
LEU B 142
ASN B 159
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y1Y_A_HNQA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		6yor IGG H CHAIN
(Homo
sapiens)		4 / 8
PRO H 189
VAL H 186
LEU H 142
ASN H 159
1.39A
None